UK markets closed

NIKKEI 225
38,274.05
-131.61(-0.34%)
HANG SENG
17,763.03
+16.12(+0.09%)
CRUDE OIL
79.13
-2.80(-3.42%)
GOLD FUTURES
2,334.20
+31.30(+1.36%)
DOW
38,299.31
+483.39(+1.28%)
Bitcoin GBP
47,039.03
-900.17(-1.88%)

Family finances

Who is the breadwinner in your family and does it matter?

BNTX Jan 2025 270.000 call

OPR - OPR Delayed price. Currency in USD

Add to watchlist

0.2600

0.0000

(0.00%)

As of 11:23AM EDT. Market open.

Zacks
BioNTech (BNTX) to Report Q1 Earnings: Is a Beat in Store?
On BioNTech's (BNTX) first-quarter 2024 earnings call, investors' focus is likely to be on the updates related to its pipeline development now that the pandemic is over.
The Telegraph
Wall Street plunges after US inflation shock
US stock markets plunged amid fears of stagflation in the American economy, which grew at its slowest pace in nearly two years just as inflation jumped.
Reuters
UPDATE 3-GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology
GlaxoSmithKline sued Pfizer and BioNTech in Delaware federal court on Thursday, accusing them of infringing GSK patents related to messenger RNA (mRNA) technology in the companies' blockbuster COVID-19 vaccines. GSK said in the lawsuit that Pfizer and BioNTech's Comirnaty vaccines violate the company's patent rights in mRNA-vaccine innovations developed "more than a decade before" the outbreak of the COVID-19 pandemic.